Infarct-related coronary artery patency and medication use prior to ST-segment elevation myocardial infarction

Christina R. Robinson, Justin L. Martin, Lily Zhang, Russell M. Canham, Shuaib M Abdullah, Joaquin E. Cigarroa, L. David Hillis, Sabina A. Murphy, Darren K McGuire, James A de Lemos, Ellen C. Keeley

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

In patients who have ST-segment elevation myocardial infarction (STEMI), a patent infarct-related artery on the initial angiogram is associated with improved clinical outcomes, including decreased mortality. The present study assessed the influence of administering aspirin, β blockers, statins, and angiotensin-converting enzyme inhibitors before STEMI on infarct-related artery patency. Our data demonstrate that patients who have STEMI and receive these medications on an outpatient basis before the event have a higher likelihood of having a patent infarct-related artery compared with patients who do not receive these medications. Further, our data demonstrate a graded association according to the number of such medications being administered: the likelihood of a patent infarct-related artery increased to >50% as the number of these medications increased.

Original languageEnglish (US)
Pages (from-to)7-9
Number of pages3
JournalAmerican Journal of Cardiology
Volume97
Issue number1
DOIs
StatePublished - Jan 1 2006

Fingerprint

Coronary Vessels
Arteries
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Angiotensin-Converting Enzyme Inhibitors
Aspirin
Angiography
Outpatients
Mortality
ST Elevation Myocardial Infarction

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Infarct-related coronary artery patency and medication use prior to ST-segment elevation myocardial infarction. / Robinson, Christina R.; Martin, Justin L.; Zhang, Lily; Canham, Russell M.; Abdullah, Shuaib M; Cigarroa, Joaquin E.; Hillis, L. David; Murphy, Sabina A.; McGuire, Darren K; de Lemos, James A; Keeley, Ellen C.

In: American Journal of Cardiology, Vol. 97, No. 1, 01.01.2006, p. 7-9.

Research output: Contribution to journalArticle

Robinson, Christina R. ; Martin, Justin L. ; Zhang, Lily ; Canham, Russell M. ; Abdullah, Shuaib M ; Cigarroa, Joaquin E. ; Hillis, L. David ; Murphy, Sabina A. ; McGuire, Darren K ; de Lemos, James A ; Keeley, Ellen C. / Infarct-related coronary artery patency and medication use prior to ST-segment elevation myocardial infarction. In: American Journal of Cardiology. 2006 ; Vol. 97, No. 1. pp. 7-9.
@article{fadde54a88ae47e8b7312f07f2d96a38,
title = "Infarct-related coronary artery patency and medication use prior to ST-segment elevation myocardial infarction",
abstract = "In patients who have ST-segment elevation myocardial infarction (STEMI), a patent infarct-related artery on the initial angiogram is associated with improved clinical outcomes, including decreased mortality. The present study assessed the influence of administering aspirin, β blockers, statins, and angiotensin-converting enzyme inhibitors before STEMI on infarct-related artery patency. Our data demonstrate that patients who have STEMI and receive these medications on an outpatient basis before the event have a higher likelihood of having a patent infarct-related artery compared with patients who do not receive these medications. Further, our data demonstrate a graded association according to the number of such medications being administered: the likelihood of a patent infarct-related artery increased to >50{\%} as the number of these medications increased.",
author = "Robinson, {Christina R.} and Martin, {Justin L.} and Lily Zhang and Canham, {Russell M.} and Abdullah, {Shuaib M} and Cigarroa, {Joaquin E.} and Hillis, {L. David} and Murphy, {Sabina A.} and McGuire, {Darren K} and {de Lemos}, {James A} and Keeley, {Ellen C.}",
year = "2006",
month = "1",
day = "1",
doi = "10.1016/j.amjcard.2005.07.103",
language = "English (US)",
volume = "97",
pages = "7--9",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Infarct-related coronary artery patency and medication use prior to ST-segment elevation myocardial infarction

AU - Robinson, Christina R.

AU - Martin, Justin L.

AU - Zhang, Lily

AU - Canham, Russell M.

AU - Abdullah, Shuaib M

AU - Cigarroa, Joaquin E.

AU - Hillis, L. David

AU - Murphy, Sabina A.

AU - McGuire, Darren K

AU - de Lemos, James A

AU - Keeley, Ellen C.

PY - 2006/1/1

Y1 - 2006/1/1

N2 - In patients who have ST-segment elevation myocardial infarction (STEMI), a patent infarct-related artery on the initial angiogram is associated with improved clinical outcomes, including decreased mortality. The present study assessed the influence of administering aspirin, β blockers, statins, and angiotensin-converting enzyme inhibitors before STEMI on infarct-related artery patency. Our data demonstrate that patients who have STEMI and receive these medications on an outpatient basis before the event have a higher likelihood of having a patent infarct-related artery compared with patients who do not receive these medications. Further, our data demonstrate a graded association according to the number of such medications being administered: the likelihood of a patent infarct-related artery increased to >50% as the number of these medications increased.

AB - In patients who have ST-segment elevation myocardial infarction (STEMI), a patent infarct-related artery on the initial angiogram is associated with improved clinical outcomes, including decreased mortality. The present study assessed the influence of administering aspirin, β blockers, statins, and angiotensin-converting enzyme inhibitors before STEMI on infarct-related artery patency. Our data demonstrate that patients who have STEMI and receive these medications on an outpatient basis before the event have a higher likelihood of having a patent infarct-related artery compared with patients who do not receive these medications. Further, our data demonstrate a graded association according to the number of such medications being administered: the likelihood of a patent infarct-related artery increased to >50% as the number of these medications increased.

UR - http://www.scopus.com/inward/record.url?scp=29244448972&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=29244448972&partnerID=8YFLogxK

U2 - 10.1016/j.amjcard.2005.07.103

DO - 10.1016/j.amjcard.2005.07.103

M3 - Article

C2 - 16377273

AN - SCOPUS:29244448972

VL - 97

SP - 7

EP - 9

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 1

ER -